Zhou, Liang
Zhang, Yahui
Chen, Wenyu
Niu, Niu
Zhao, Junjie
Qi, Weibo
Xu, Yufen
Funding for this research was provided by:
Natural Science Foundation of Zhejiang province (NO. LQ20H160057, NO. LQ20H160057, NO. LQ20H160057, NO. LQ20H160057, NO. LQ20H160057, NO. LQ20H160057, NO. LQ20H160057)
the Key Discipline of Jiaxing Medicine Construction Project (grant No.2019-zc-04,2019-zc-09,2019-zc-11, grant No.2019-zc-04,2019-zc-09,2019-zc-11, grant No.2019-zc-04,2019-zc-09,2019-zc-11, grant No.2019-zc-04,2019-zc-09,2019-zc-11, grant No.2019-zc-04,2019-zc-09,2019-zc-11, grant No.2019-zc-04,2019-zc-09,2019-zc-11, grant No.2019-zc-04,2019-zc-09,2019-zc-11)
the Jiaxing Key Laboratory of Precision Treatment for Lung Cancer,Scientific Technology Plan Program for Healthcare in Zhejiang Province (NO. 2021RC031,2022KY377, NO. 2021RC031,2022KY377, NO. 2021RC031,2022KY377, NO. 2021RC031,2022KY377, NO. 2021RC031,2022KY377, NO. 2021RC031,2022KY377, NO. 2021RC031,2022KY377)
Science and technology project of Jiaxing (2019AY32030,2020AY30012,2021AY30024, 2019AY32030,2020AY30012,2021AY30024, 2019AY32030,2020AY30012,2021AY30024, 2019AY32030,2020AY30012,2021AY30024, 2019AY32030,2020AY30012,2021AY30024, 2019AY32030,2020AY30012,2021AY30024, 2019AY32030,2020AY30012,2021AY30024)
Article History
Received: 29 April 2022
Accepted: 5 September 2022
First Online: 14 September 2022
Declarations
:
: This study was approved by the Ethics Committee of Jiaxing First Hospital (zhejiang, China) (Ethics No.LS2021-KY-140). All patients or next-of-kin in the external validation cohort provided written informed consent for the case details to be published. We were permitted to have Internet access to the SEER database (ExternalRef removed) by the SEER administration. This study was conducted in concordance with the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.